ivabradine has been researched along with Hypertension in 27 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 24 (88.89) | 24.3611 |
| 2020's | 3 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Cangussú, SD; Chianca-Jr, DA; Chírico, MTT; de Menezes, RCA; Gomes, FAR; Machado-Júnior, PA; Montano, N; Noronha, SISR; Ostolin, TLVP; Reis, AB; Ribeiro, MC; Silva, FC; Silva, SCA; Silva, VJD | 1 |
| Lockette, W; Miller, C; Student, J; Woodman, R | 1 |
| Wang, PH | 1 |
| Berdeaux, A; Bizé, A; Bouhemad, B; Ghaleh, B; Hittinger, L; Jozwiak, M; Melka, J; Rienzo, M; Sambin, L; Su, JB | 1 |
| Chaanine, AH; Gladden, JD; Redfield, MM | 1 |
| Wu, A | 1 |
| Adamcova, M; Aziriova, S; Baka, T; Krajcirovicova, K; Paulis, L; Repova, K; Simko, F | 1 |
| Akiyama, T; Iwanaga, Y; Kakehi, K; Miyazaki, S; Shimizu, S; Sonobe, T; Watanabe, H; Yamamoto, H | 1 |
| Baka, T; Simko, F | 1 |
| Gapon, LI; Kolesnikova, SN; Musikhina, NA; Petelina, TI; Utesheva, AB | 1 |
| Fichtlscherer, S; Fischer-Rasokat, U; Hamm, C; Honold, J; Leick, J; Liebetrau, C; Lochmann, D; Möllmann, H; Spyridopoulos, I | 1 |
| Böhm, M; Borer, JS; Ford, I; Komajda, M; Manolis, AJ; Robertson, M; Swedberg, K; Tavazzi, L | 1 |
| Berdeaux, A; Bizé, A; Ghaleh, B; Hittinger, L; Jozwiak, M; Melka, J; Rienzo, M; Sambin, L; Su, JB | 2 |
| Bangalore, S; Messerli, FH; Schmieder, RE | 1 |
| Caetano, J; Delgado Alves, J | 1 |
| Ashrafian, H; Dawson, DK; Dwight, JS; Francis, JM; Frenneaux, M; Mahmod, M; Neubauer, S; Pal, N; Rudd, A; Singh, S; Sivaswamy, N; Watkins, H; Yavari, A | 1 |
| Davis, K; Dietrich, E | 1 |
| Adamcova, M; Aziriova, S; Baka, T; Hodosy, J; Krajcirovicova, K; Mojto, V; Paulis, L; Repova, K; Simko, F; Slavkovsky, P; Zorad, S | 1 |
| Odegova, AA; Tarlovskaya, EI | 1 |
| Kanorskiy, SG; Pokrovskiy, VM; Tregubov, VG | 1 |
| Bugatti, S; Dei Cas, L; Lombardi, C; Metra, M; Zacà, V | 1 |
| Kurpesa, M; Rechciński, T; Trzos, E; Wierzbowska-Drabik, K | 1 |
| Kanorskiĭ, SG; Pokrovskiĭ, VM; Tregubov, VG | 1 |
| Daiber, A; Hortmann, M; Kleschyov, AL; Kröller-Schön, S; Münzel, T; Oelze, M; Renné, T; Schulz, E; Torzewski, M; Wenzel, P | 1 |
| Hedner, T; Kjeldsen, SE; Narkiewicz, K; Oparil, S | 1 |
| Drożdż, J; Filipiak, KJ; Grajek, S; Kasprzak, JD; Opolski, G; Rynkiewicz, A; Stępińska, J; Tykarski, A; Wożakowska Kapłon, B | 1 |
6 review(s) available for ivabradine and Hypertension
| Article | Year |
|---|---|
Heart Failure with Preserved Ejection Fraction.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Cardiovascular Agents; Dyspnea; Exercise Tolerance; Heart Failure; Hospitalization; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Incidence; Inflammation; Ivabradine; Mineralocorticoid Receptor Antagonists; Mortality; Nitrates; Phosphodiesterase 4 Inhibitors; Risk Factors; Stroke Volume | 2018 |
Heart Failure.
Topics: Adrenergic beta-Antagonists; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anticoagulants; Cardiac Rehabilitation; Cardiovascular Agents; Coronary Artery Disease; Defibrillators, Implantable; Diabetes Complications; Diagnostic Techniques, Cardiovascular; Digoxin; Diuretics; Heart Failure; Hospitalization; Humans; Hydralazine; Hypertension; Isosorbide Dinitrate; Ivabradine; Life Style; Mineralocorticoid Receptor Antagonists; Palliative Care; Primary Prevention; Referral and Consultation; Risk Factors | 2018 |
Wilder's principle: pre-treatment value determines post-treatment response.
Topics: Antihypertensive Agents; Benzazepines; Blood Pressure; Cardiovascular Agents; Heart Rate; Humans; Hypertension; Ivabradine; Randomized Controlled Trials as Topic | 2015 |
Heart rate and cardiovascular protection.
Topics: Adrenergic beta-Antagonists; Arrhythmias, Cardiac; Atherosclerosis; Benzazepines; Cardiovascular Agents; Clinical Trials as Topic; Heart Failure; Heart Rate; Humans; Hypertension; Ivabradine; Myocardial Ischemia; Risk Factors | 2015 |
Ivabradine (Corlanor) for Heart Failure.
Topics: Atrial Fibrillation; Benzazepines; Bradycardia; Cardiovascular Agents; Drug Costs; Heart Failure; Humans; Hypertension; Ivabradine; Treatment Outcome | 2016 |
[Heart rate: a risk factor or an epiphenomenon?].
Topics: Acute Coronary Syndrome; Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Benzazepines; Calcium Channel Blockers; Cohort Studies; Cyclic Nucleotide-Gated Cation Channels; Female; Follow-Up Studies; Heart Failure; Heart Rate; Hospitalization; Humans; Hypertension; Ivabradine; Male; Middle Aged; Multivariate Analysis; Myocardial Ischemia; Prognosis; Randomized Controlled Trials as Topic; Risk Factors; Stereoisomerism; Tachycardia; Time Factors; Ventricular Dysfunction, Left | 2010 |
5 trial(s) available for ivabradine and Hypertension
| Article | Year |
|---|---|
[Cerebral blood flow and endothelial functional activity in patients with coronary heart disease and arterial hypertension during therapy with ivabradine in combination with perindopril].
Topics: Benzazepines; Blood Flow Velocity; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Cardiovascular Agents; Cerebrovascular Circulation; Coronary Disease; Drug Combinations; Electrocardiography; Endothelium, Vascular; Female; Heart Rate; Humans; Hypertension; Ivabradine; Male; Metoprolol; Middle Aged; Perindopril; Research Design; Treatment Outcome; Ultrasonography, Doppler | 2012 |
Ivabradine therapy to unmask heart rate-independent effects of β-blockers on pulse wave reflections.
Topics: Adrenergic beta-Antagonists; Benzazepines; Coronary Artery Disease; Exercise Test; Heart Rate; Humans; Hypertension; Ivabradine; Male; Middle Aged; Pulse Wave Analysis; Renin-Angiotensin System | 2014 |
Efficacy and safety of ivabradine in patients with chronic systolic heart failure according to blood pressure level in SHIFT.
Topics: Aged; Benzazepines; Blood Pressure; Cardiovascular Agents; Double-Blind Method; Female; Heart Failure, Systolic; Humans; Hypertension; Hypotension; Ivabradine; Male; Middle Aged; Prognosis; Systole; Treatment Outcome | 2014 |
Effect of Selective Heart Rate Slowing in Heart Failure With Preserved Ejection Fraction.
Topics: Aged; Aged, 80 and over; Asymptomatic Diseases; Benzazepines; Biomarkers; Cross-Over Studies; Cyclic Nucleotide-Gated Cation Channels; Double-Blind Method; Endpoint Determination; Exercise Test; Exercise Tolerance; Female; Heart Failure; Heart Rate; Humans; Hypertension; Ivabradine; Male; Middle Aged; Natriuretic Peptide, Brain; Oxygen Consumption; Sinoatrial Node; Stroke Volume; Treatment Failure | 2015 |
[Alternative therapy with ivabradine in patients with functional class III chronic heart failure].
Topics: Benzazepines; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Cardiovascular Agents; Chronic Disease; Drug Monitoring; Drug Therapy, Combination; Echocardiography; Exercise Tolerance; Female; Heart Failure; Heart Rate; Humans; Hypertension; Ivabradine; Male; Middle Aged; Natriuretic Peptide, Brain; Oxygen Consumption; Peptide Fragments; Severity of Illness Index; Treatment Outcome | 2011 |
16 other study(ies) available for ivabradine and Hypertension
| Article | Year |
|---|---|
Ivabradine treatment lowers blood pressure and promotes cardiac and renal protection in spontaneously hypertensive rats.
Topics: Animals; Blood Pressure; Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels; Hypertension; Ivabradine; Kidney; Nucleotides, Cyclic; Rats; Rats, Inbred SHR; Rats, Inbred WKY; RNA, Messenger | 2022 |
Ivabradine-Induced Bradycardia is Accompanied by Reduced Stress-Related Anxiety.
Topics: Animals; Anxiety; Bradycardia; Heart Rate; Hypertension; Ivabradine; Mice; Quality of Life | 2023 |
Drug for heart is applicable to liver: Is it possible?
Topics: Animals; Heart; Hypertension; Ivabradine; Liver; Pharmaceutical Preparations; Rats | 2020 |
Ivabradine improves left ventricular twist and untwist during chronic hypertension.
Topics: Animals; Benzazepines; Cardiovascular Agents; Chronic Disease; Female; Hypertension; Hypertrophy, Left Ventricular; Ivabradine; Swine; Ventricular Dysfunction, Left | 2018 |
Ivabradine does not impair anxiety-like behavior and memory in both healthy and L-NAME-induced hypertensive rats.
Topics: Animals; Anxiety; Blood Pressure; Enzyme Inhibitors; Heart Rate; Hypertension; Ivabradine; Male; Memory; NG-Nitroarginine Methyl Ester; Rats; Rats, Wistar | 2018 |
Modulation of Sympathetic Activity and Innervation With Chronic Ivabradine and β-Blocker Therapies: Analysis of Hypertensive Rats With Heart Failure.
Topics: Adrenergic beta-1 Receptor Antagonists; Animals; Bisoprolol; Cardiovascular Agents; Disease Models, Animal; Heart; Heart Failure; Heart Rate; Hypertension; Ivabradine; Male; Myocardium; Norepinephrine; Parasympathetic Nervous System; Rats, Inbred Dahl; Sodium Chloride, Dietary; Sympathetic Nervous System; Tyrosine 3-Monooxygenase; Ventricular Function, Left | 2019 |
Ivabradine reversed nondipping heart rate in rats with l-NAME-induced hypertension.
Topics: Animals; Circadian Rhythm; Heart Rate; Hypertension; Ivabradine; NG-Nitroarginine Methyl Ester; Rats; Rats, Wistar; Rest | 2019 |
Ivabradine improves left ventricular function during chronic hypertension in conscious pigs.
Topics: Animals; Benzazepines; Consciousness; Cyclic Nucleotide-Gated Cation Channels; Disease Models, Animal; Female; Heart Ventricles; Hypertension; Ivabradine; Swine; Treatment Outcome; Ventricular Function, Left; Ventricular Remodeling | 2015 |
Improvement of left ventricular filling by ivabradine during chronic hypertension: involvement of contraction-relaxation coupling.
Topics: Animals; Benzazepines; Cardiovascular Agents; Disease Models, Animal; Female; Hemodynamics; Hypertension; Ivabradine; Swine; Ventricular Function, Left | 2016 |
Effect of ivabradine, captopril and melatonin on the behaviour of rats in L-nitro-arginine methyl ester-induced hypertension.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Behavior, Animal; Benzazepines; Blood Pressure; Captopril; Heart Rate; Hypertension; Ivabradine; Locomotion; Male; Melatonin; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Rats; Rats, Wistar | 2016 |
[Assessment of Efficiency of Medicamentous Therapy in Correction of Structurally Functional Changes of The Cardiac Muscle at Patients With Arterial Hypertension in Combination With Bronchial Asthma].
Topics: Aged; Asthma; Benzazepines; Cardiovascular Agents; Electrocardiography; Electrocardiography, Ambulatory; Heart; Heart Rate; Humans; Hypertension; Ivabradine; Middle Aged | 2016 |
[Regulatory Adaptive Status in Assessment of Efficacy of Pharmacotherapy and Prognostication of Complications in Functional Class III Chronic Heart Failure].
Topics: Aged; Benzazepines; Cardiovascular Agents; Chronic Disease; Echocardiography; Exercise Test; Female; Heart Failure; Humans; Hypertension; Ivabradine; Male; Metoprolol; Middle Aged; Quinapril; Random Allocation; Spironolactone; Tetrahydroisoquinolines; Treatment Outcome; Ventricular Function, Left | 2016 |
Ivabradine as a heart rate-lowering agent in a patient with end-stage renal failure after heart transplantation.
Topics: Benzazepines; Electrocardiography, Ambulatory; Female; Heart Rate; Heart Transplantation; Humans; Hypertension; Ivabradine; Kidney Failure, Chronic; Middle Aged; Pulmonary Disease, Chronic Obstructive; Renal Dialysis | 2010 |
Differential effects of heart rate reduction with ivabradine in two models of endothelial dysfunction and oxidative stress.
Topics: Animals; Apolipoproteins E; Atherosclerosis; Benzazepines; Chromatography, High Pressure Liquid; Disease Models, Animal; Endothelium, Vascular; Heart Rate; Hemodynamics; Humans; Hypertension; Immunoblotting; Ivabradine; Luminescence; Male; Mice; Mice, Knockout; Neutrophils; Oxidative Stress; Rats; Rats, Wistar; Reactive Oxygen Species; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction | 2011 |
Increased time varying heart rate and cardiovascular risk in hypertension: benefit of selective I((f)) channel inhibitor?
Topics: Benzazepines; Clinical Trials as Topic; Heart; Heart Rate; Humans; Hypertension; Ion Channels; Ivabradine; Risk; Tachycardia | 2012 |
[Optimum heart rate - the current goal of cardiovascular therapy. Position statement of the Polish Cardiac Society Working Group on Cardiovascular Drug Therapy].
Topics: Adrenergic beta-Agonists; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzazepines; Digoxin; Diltiazem; Heart Diseases; Heart Rate; Humans; Hypertension; Ivabradine; Verapamil | 2012 |